Half of all pancreatic-cancer patients live less than a year after diagnosis. But researchers say there is potential for change.

After portasystemic-shunt operations in 2 of 20 patients with cirrhosis minimal hepatocellular siderosis developed, in 1 extensive hepatic siderosis with pancreatic fibrosis and siderosis, and in ...

Pancreatic cancer is one of the most difficult cancers to treat — and the deadliest. Fewer than 10% of patients with advanced pancreatic cancer live beyond five years. A few factors account for this.

BUFFALO, N.Y. — Pancreatic cancer is one of the most difficult cancers to treat — and the deadliest. Fewer than 10% of patients with advanced pancreatic cancer live beyond five years. A few factors ...

An Oregon teenager’s innovation could change the way doctors treat pancreatic cancer, a deadly form of the disease that has just a 7% five-year survival rate. Rishab Jain, a 13-year-old from ...

Emergency portacaval shunt versus rescue portacaval shunt in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis--part 3. Clinical presentation ...

Reference center for Catalonia It is worth mentioning that Bellvitge is a reference center in pancreatic surgery, especially in the resection of locally advanced pancreatic tumors.

A woman whose mother died from pancreatic cancer has joined calls for more government investment in research. Sam Weldon, from Wimborne in Dorset, lost her 78-year-old mother Sylvia Lloyd in ...

Pancreatic cancer involving the celiac artery often requires an Appleby procedure consisting of a distal pancreatectomy, en-bloc splenectomy, and resection of the celiac artery.

Transabdominal ultrasound shows potential as an alternative and cost-effective method for monitoring selected patients with cystic pancreatic lesions.